DNTH stock news
This page provides real-time market news, earnings updates, and company announcements related to Dianthus Therapeutics, Inc. (DNTH).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-18 02:45 EST
Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
Finviz2026-02-24 12:03:58
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-03 21:03:12
Dianthus Jumps 11.2% Amid Dramatic Intraday Spike – What’s Driving the Rapid Rise?
101 finance2026-03-04 15:24:46
Dianthus Jumps 11.2% Amid Dramatic Intraday Spike – What’s Driving the Upswing?
101 finance2026-03-04 15:24:46
Dianthus Therapeutics, Inc. (DNTH) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations
101 finance2026-03-09 13:30:56
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
Finviz2026-03-09 20:06:46
Investment firm Raymond James announced an upgrade of biopharmaceutical company Dianthus Therapeutics Inc. (DNTH) stock rating from "Outperform" to "Strong Buy".
老虎证券2026-03-10 11:51:37
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
Finviz2026-03-11 02:57:43
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Finviz2026-03-12 20:06:49
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-16 11:03:45
Dianthus Therapeutics, Inc. (DNTH) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations
101 finance2026-03-09 13:30:56
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
Finviz2026-03-09 20:06:46
Investment firm Raymond James announced an upgrade of biopharmaceutical company Dianthus Therapeutics Inc. (DNTH) stock rating from "Outperform" to "Strong Buy".
老虎证券2026-03-10 11:51:37
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
Finviz2026-03-11 02:57:43
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Finviz2026-03-12 20:06:49
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-16 11:03:45
DNTH stock chart
DNTH stock detailsDNTH stock price change
On the last trading day, DNTH stock closed at 79.24 USD, with a price change of 1.59% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more